Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03263338 · ClinicalTrials.gov registry record · NA

Mobile Sleep and Growth Study

A NA study of Childhood Sleep Promotion, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT03263338: Completed NA study of Childhood Sleep Promotion, sponsored by Children's Hospital of Philadelphia.

NCT03263338 is a NA study of Childhood Sleep Promotion that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03263338, a NA study of Childhood Sleep Promotion, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to see if we can help parents to get their children to go to bed earlier. This may help children to improve their sleep. The study will use a web-based study platform and an activity monitor.

Primary Outcome

Time in bed is estimated using a Fitbit activity tracker

Conditions Studied

Interventions

  • BEHAVIORAL Mobile Sleep and Growth Study

Study Locations (1)

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2017-08-10
Est. Completion 2018-06-06
Phase NA
Children's Hospital of Philadelphia

431 total trials

What the finished NCT03263338 record still lists

NCT03263338 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Childhood Sleep Promotion appearing as the primary indexed condition, and to 1 intervention - of which Mobile Sleep and Growth Study is the first listed.

NCT03263338 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03263338 about?

NCT03263338 is a clinical study titled "Mobile Sleep and Growth Study". The purpose of this research study is to see if we can help parents to get their children to go to bed earlier. This may help children to improve their sleep. The study will use a web-based study platform and an activity monitor.

What is the current status of trial NCT03263338?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2017-08-10. Estimated completion is 2018-06-06.

What conditions does trial NCT03263338 study?

This clinical trial studies the following conditions: Childhood Sleep Promotion.

What interventions are being tested in trial NCT03263338?

The interventions under investigation include: Mobile Sleep and Growth Study (BEHAVIORAL).

Who is sponsoring clinical trial NCT03263338?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03263338 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03263338's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03263338, the US trial registry maintained by the National Library of Medicine. NCT03263338 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.